DGX Quest Diagnostics Earnings and EPS analysis

EPS in 2025 (TTM): $8.47

Last Report Period Date: Jun 30, 2025

As of July 2025, according to Quest Diagnostics's current financial statements, the company's 12-month EPS is $8.47. For the year 2024, the company recorded an earnings per share (EPS) of $7.78, which marks an increase compared to its EPS of $7.59 in 2023. Quest Diagnostics's earnings per share for the quarterly report ending on Jun 30, 2025 reached $2.51.

The annual EPS for the year 2024 was $7.78, an increase of 2.5% from $7.59 in 2023. For the fiscal quarter that ended on Jun 30, 2025, the per-share earnings was $2.51, showing a 22.4% increase from the same quarter last year. For the twelve months ending June 2025, the EPS is $8.47. For the year 2023, the yearly earnings per share was $7.59, marking a decrease of 6.3% from 2022.

During the last 12 months, Quest Diagnostics has seen an EPS growth of 22.4% (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of -21.1% per year for the last three years. During the last 5 years, the company had an average EPS growth rate of 4.1%. A 10-year view shows that DGX has seen an average EPS growth of 7.3% per year.